These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
270 results:

  • 1. A syngeneic spontaneous zebrafish model of
    Weiss A; D'Amata C; Pearson BJ; Hayes MN
    Elife; 2024 Jul; 13():. PubMed ID: 39052000
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A case series of osseous metastases in patients with glioblastoma.
    Webb LM; Webb MJ; Campian JL; Caron SJ; Ruff MW; Uhm JH; Sener U
    Medicine (Baltimore); 2024 Jul; 103(27):e38794. PubMed ID: 38968484
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular Pathology of Gliomas.
    Galbraith K; Snuderl M
    Clin Lab Med; 2024 Jun; 44(2):149-159. PubMed ID: 38821638
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Principles in the Management of Glioblastoma.
    Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
    Lim-Fat MJ; Iorgulescu JB; Rahman R; Bhave V; Muzikansky A; Woodward E; Whorral S; Allen M; Touat M; Li X; Xy G; Patel J; Gerstner ER; Kalpathy-Cramer J; Youssef G; Chukwueke U; McFaline-Figueroa JR; Nayak L; Lee EQ; Reardon DA; Beroukhim R; Huang RY; Bi WL; Ligon KL; Wen PY
    Clin Cancer Res; 2024 Apr; 30(7):1327-1337. PubMed ID: 38252427
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
    Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
    Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
    Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
    Tateishi K; Miyake Y; Nakamura T; Iwashita H; Hayashi T; Oshima A; Honma H; Hayashi H; Sugino K; Kato M; Satomi K; Fujii S; Komori T; Yamamoto T; Cahill DP; Wakimoto H
    Acta Neuropathol Commun; 2023 Nov; 11(1):186. PubMed ID: 38012788
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
    Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
    [No Abstract]    [Full Text] [Related]  

  • 11. Practice of IDH1, ATRX, and p53 Immunohistochemistry in Integrated diagnosis of Adult Diffuse Gliomas: Single Center Study.
    Shabanzadeh Nejabad Z; Mabroukzadeh Kavari H; Saffar H; Tavangar SM; Sefidbakht S; Khoshnevisan A; Zare-Mirzaie A; Vasei M; Jafari E; Yaghmaii M; Saffar H
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):390-398. PubMed ID: 37278280
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
    Quddusi DM; Bajcinca N
    IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
    Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
    JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
    Lee K; Kim SI; Kim EE; Shim YM; Won JK; Park CK; Choi SH; Yun H; Lee H; Park SH
    Sci Rep; 2023 Apr; 13(1):6761. PubMed ID: 37185778
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exploration of NPC2 as a Potential Biomarker for Immunotherapy Using RNA-seq and Protein Data - A New Hypothesis.
    Lu W; Li D; Tao F; Chen Q; Fan S; Ma Y; Dong H; Hu Y; Yue C
    Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1340-1353. PubMed ID: 37056065
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].
    Yang QY; Li MN; Chen TY; Liu C; Li X; Shi ZM; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):376-383. PubMed ID: 36973199
    [No Abstract]    [Full Text] [Related]  

  • 17. Signaling Pathways in the Relapse of Glioblastoma.
    Orozco-Mera J; Peralta-Pizza F; Escobar-Vidarte O; Coll-Tello B; Ariza A
    Oncology (Williston Park); 2023 Mar; 37(3):107-117. PubMed ID: 36961958
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
    Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
    Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Report of Multidisciplinary Treatment for Sisters with Li-Fraumeni Syndrome].
    Suzuki O; Amano K; Chika N; Yamano T; Eguchi H; Nakashima H; Ooya S; Okazaki Y; Mochiki E; Takahashi T; Ishida H
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1947-1949. PubMed ID: 36733053
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.